Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07469475) titled 'Effect of a Daily Supplement on Plasma PAI-1 Levels' on March 5.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: University of California, Los Angeles
Condition:
Aging
Endothelial Dysfunction
Senescence
Intervention:
Dietary Supplement: Supplement with ginger extract, L-citrulline, Paullinia cupana, and muira puama
Recruitment Status: Recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: February 24, 2026
Target Sample Size: 35
Countries of Recruitment:
United States
...